JP2022524930A5 - - Google Patents

Info

Publication number
JP2022524930A5
JP2022524930A5 JP2021545301A JP2021545301A JP2022524930A5 JP 2022524930 A5 JP2022524930 A5 JP 2022524930A5 JP 2021545301 A JP2021545301 A JP 2021545301A JP 2021545301 A JP2021545301 A JP 2021545301A JP 2022524930 A5 JP2022524930 A5 JP 2022524930A5
Authority
JP
Japan
Prior art keywords
understand
heteroaralkyl
heterocycloalkyl
aralkyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021545301A
Other languages
English (en)
Japanese (ja)
Other versions
JP7580380B2 (ja
JP2022524930A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019600 external-priority patent/WO2020176445A1/en
Publication of JP2022524930A publication Critical patent/JP2022524930A/ja
Publication of JP2022524930A5 publication Critical patent/JP2022524930A5/ja
Application granted granted Critical
Publication of JP7580380B2 publication Critical patent/JP7580380B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021545301A 2019-02-26 2020-02-25 運動ニューロン疾患を処置するための方法及び組成物 Active JP7580380B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962810728P 2019-02-26 2019-02-26
US62/810,728 2019-02-26
US201962892754P 2019-08-28 2019-08-28
US62/892,754 2019-08-28
PCT/US2020/019600 WO2020176445A1 (en) 2019-02-26 2020-02-25 Methods and compositions for treating motor neuron diseases

Publications (3)

Publication Number Publication Date
JP2022524930A JP2022524930A (ja) 2022-05-11
JP2022524930A5 true JP2022524930A5 (enExample) 2022-09-27
JP7580380B2 JP7580380B2 (ja) 2024-11-11

Family

ID=72239986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021545301A Active JP7580380B2 (ja) 2019-02-26 2020-02-25 運動ニューロン疾患を処置するための方法及び組成物

Country Status (5)

Country Link
US (1) US12350283B2 (enExample)
EP (1) EP3930728A1 (enExample)
JP (1) JP7580380B2 (enExample)
CN (1) CN113473993B (enExample)
WO (1) WO2020176445A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118401539A (zh) 2021-12-15 2024-07-26 兆维生物科技公司 官能化的n-乙酰半乳糖胺类似物
US12116382B2 (en) 2022-11-28 2024-10-15 Hongene Biotech Corporation Functionalized N-acetylgalactosamine analogs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219552A1 (en) * 2001-08-14 2004-11-04 Ali Ait Ikhlef Novel molecular target for neurotoxicity
CA2693697C (en) * 2007-07-11 2017-07-25 Medicinova, Inc. Treatment of progressive neurodegenerative disease with ibudilast
CN107849083A (zh) * 2015-06-10 2018-03-27 益力舒健康公司 用于治疗皮肤病症的烟酰胺核苷和紫檀芪组合物和方法
EP3429354A4 (en) * 2016-03-16 2020-03-25 Chromadex Inc. B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF AND METHOD FOR THE PRODUCTION THEREOF
JP7132907B2 (ja) 2016-08-22 2022-09-07 エリジウム・ヘルス・インコーポレイテッド ニコチンアミドリボシド及びプテロスチルベン組成物及び神経変性障害の治療方法
WO2018058109A1 (en) * 2016-09-26 2018-03-29 Nusirt Sciences, Inc. Compositions and methods for treating metabolic disorders
ES3004332T3 (en) * 2017-05-17 2025-03-12 Univ De Valencia Estudi General Treating and preventing amyotrophic lateral sclerosis with nicotinamide riboside and pterostilbene
US11286274B2 (en) * 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses

Similar Documents

Publication Publication Date Title
ATE270103T1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
NO20062339L (no) Hepatitt C virus-inhibitoerer
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
ATE453631T1 (de) Pna-monomer und vorstufe
IS8448A (is) Lifrarbólgu C-veirutálmar
PE20060837A1 (es) COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS
SE8401331D0 (sv) Meta-phenylenediamine coupler compounds and oxidative hair dye compositions and methods using same
CY1108652T1 (el) Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων
DE3889345D1 (de) Schimmelbekämpfungsmittel.
MY140680A (en) Hepatitis c virus inhibitors
NZ505362A (en) 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents
FI964444A0 (fi) Yhdisteet, jotka sisältävät Michael-akseptorin, erityisesti maleiimi-imidi- tai maleiinihappojohdannaisen, ja jotka on sidottu kromoforiin ja niiden käyttö pitkään kestävissä auringonestokoostumuksissa
WO2003018549A3 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
JPH09324131A5 (enExample)
JP2005533839A5 (enExample)
CA2301543A1 (en) Azetidinone derivatives for the treatment of hcmv infections
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
JPH09227862A5 (enExample)
JP2005529869A5 (enExample)
TR199902197T2 (xx) Tiyazolidindionlar�n elde edilmesi i�in geli�tirilmi� y�ntem ve yeni tiyazolidindionlar.
JP2007519654A5 (enExample)
DK0778824T3 (da) Carbamoylcarboxylsyreamider
ID22444A (id) Bis (akridinkarboksamida) dan bis (fenozinkarboksamida) sebagai zat anti tumor
FR2737496B1 (fr) 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2
RU2004120783A (ru) Способ получения 2-(2-нитрофенилазо)фенолов без использования органических растворителей